Prognostic Disclosure Associated With Improved Understanding of End-of-Life Care
the ONA take:
A multicenter observational study sought to determine how prognostic conversations influence perception of life expectancy, distress, and the patient-physician relationship among patients with advanced cancer.
The study included a cohort of 590 patients with advanced cancer who were asked whether their oncologist disclosed an estimate of prognosis.
They were also asked to estimate their own life expectancy and complete assessments of the patient-physician relationship, distress, advance directives, and end-of-life care preferences.
The researchers found that 71% of patients wanted to know their life expectancy, but only 17.6% recalled their physician disclosing a prognosis; 51% were willing to estimate their own life expectancy.
Those patients who recalled a prognostic disclosure provided more realistic estimates of life expectancy compared with those who did not. In addition, their estimates were less likely to differ from their actual survival.
Patients who recalled prognostic disclosure provided an estimated life expectancy that was decreased by 17.2 months compared with those who did not recall prognostic disclosure.
Longer self-estimates of life expectancy were associated with lower likelihood of do-not-resuscitate orders and preference for life-prolonging over comfort-oriented care.
Prognostic disclosure was not associated with worse patient-physician relationship ratings, and sadness or anxiety were not increased in these patients.
How prognostic conversations influence perception of life expectancy, distress, and the patient-physician relationship among patients with advanced cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|